Simon Mooijaart<p>📢 New research alert! </p><p>📝 Our study in <a href="https://mastodon.green/tags/Thrombosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Thrombosis</span></a> and <a href="https://mastodon.green/tags/Haemostasis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Haemostasis</span></a> explores anticoagulant use in life-limiting diseases</p><p>➡️ most patients continued therapy until end-of-life with comparable risks of bleeding or clots after stopping. </p><p>✅ understanding helps to improve quality of life of future patients</p><p>🥳 Kudos to Eva Kempers! </p><p>🔗 10.1055/a-2524-5334 </p><p><a href="https://mastodon.green/tags/palliativecare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>palliativecare</span></a> <a href="https://mastodon.green/tags/geriatrics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>geriatrics</span></a> <a href="https://mastodon.green/tags/medmastodon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>medmastodon</span></a></p>